Faculty of Medicine, Department of Neurosciences, Psychiatry Research Group, University of Leuven, Leuven, Belgium.
University Psychiatric Center, KU Leuven, Leuven, Belgium.
Eur Psychiatry. 2021 Oct 13;65(1):e18. doi: 10.1192/j.eurpsy.2021.2241.
The Positive and Negative Syndrome Scale (PANSS) is widely used in schizophrenia and has been divided into distinct factors (5-factor models) and subfactors. Network analyses are newer in psychiatry and can help to better understand the relationships and interactions between the symptoms of a psychiatric disorder. The aim of this study was threefold: (a) to evaluate connections between schizophrenia symptoms in two populations of patients (patients in the acutely exacerbated phase of schizophrenia and patients with predominant negative symptoms [PNS]), (b) to test whether network analyses support the Mohr 5 factor model of the PANSS and the Kahn 2 factor model of negative symptoms, and finally (c) to identify the most central symptoms in the two populations.
Using pooled baseline data from four cariprazine clinical trials in patients with acute exacerbation of schizophrenia (n = 2193) and the cariprazine-risperidone study in patients with PNS (n = 460), separate network analyses were performed. Network structures were estimated for all 30 items of the PANSS.
While negative symptoms in patients with an acute exacerbation of schizophrenia are correlated with other PANSS symptoms, these negative symptoms are not correlated with other PANSS symptoms in patients with PNS. The Mohr factors were partially reflected in the network analyses. The two most central symptoms (largest node strength) were delusions and uncooperativeness in acute phase patients and hostility and delusions in patients with PNS.
This network analysis suggests that symptoms of schizophrenia are differently structured in acute and PNS patients. While in the former, negative symptoms are mainly secondary, in patients with PNS, they are mainly primary. Further, primary negative symptoms are better conceptualized as distinct negative symptom dimensions of the PANSS.
阳性与阴性症状量表(PANSS)在精神分裂症中应用广泛,并已分为不同的因子(5 因子模型)和亚因子。网络分析在精神病学中较为新颖,可以帮助更好地理解精神障碍症状之间的关系和相互作用。本研究旨在:(a)评估两种精神分裂症患者人群(精神分裂症急性加重期患者和以阴性症状为主的患者)中精神分裂症症状之间的联系;(b)检验网络分析是否支持 Mohr 的 PANSS 5 因子模型和 Kahn 的阴性症状 2 因子模型;最后(c)确定这两种人群中最核心的症状。
利用卡利培嗪治疗精神分裂症急性加重症的四项临床试验(n=2193)和卡利培嗪-利培酮治疗以阴性症状为主的精神分裂症患者的研究(n=460)的汇总基线数据,进行了单独的网络分析。对 PANSS 的 30 个项目进行了网络结构评估。
精神分裂症急性加重症患者的阴性症状与其他 PANSS 症状相关,而以阴性症状为主的精神分裂症患者的阴性症状与其他 PANSS 症状不相关。Mohr 因子在网络分析中部分得到反映。两个最核心的症状(最大节点强度)是急性阶段患者的妄想和不合作,以及以阴性症状为主的精神分裂症患者的敌对和妄想。
该网络分析表明,精神分裂症的症状在急性和以阴性症状为主的患者中结构不同。在前者中,阴性症状主要是次要的,而在以阴性症状为主的患者中,阴性症状主要是原发性的。此外,原发性阴性症状可以更好地被视为 PANSS 中不同的阴性症状维度。